Table 2.
Follow-up multidisciplinary assessment
| n | % | Sample size | ||||
|---|---|---|---|---|---|---|
| Patients feeling recovered | 510 | 66.5 | 767 | |||
| Days since patients have felt recovered, median (IQR) | 49 (30–72) | 510 | ||||
| Persistent symptoms at follow-up visit | ||||||
| F | M | F | M | F | M | |
| None | 97 | 276 | 38.5 | 53.6 | 252 | 515 |
| Confusion | 7 | 16 | 2.8 | 3.1 | 252 | 515 |
| Asthenia | 93 | 93 | 36.9 | 18.1 | 252 | 515 |
| Dyspnoea | 66 | 101 | 26.2 | 19.6 | 252 | 515 |
| Fever | 1 | 3 | 0.4 | 0.6 | 252 | 515 |
| Myalgia | 9 | 20 | 3.6 | 3.9 | 252 | 515 |
| Cough | 8 | 15 | 3.2 | 2.9 | 252 | 515 |
| Headache | 1 | 3 | 0.4 | 0.6 | 252 | 515 |
| Chest pain | 9 | 15 | 3.6 | 2.9 | 252 | 515 |
| Palpitations | 18 | 12 | 7.1 | 2.3 | 252 | 515 |
| Syncope | 0 | 1 | 0.0 | 0.2 | 252 | 515 |
| Anosmia/Dysgeusia | 11 | 12 | 4.4 | 2.3 | 252 | 515 |
| Upper gastro-intestinal symptoms | 1 | 0 | 0.4 | 0.0 | 252 | 515 |
| Lower gastro-intestinal symptoms | 4 | 3 | 1.6 | 0.6 | 252 | 515 |
| Othersa | 13 | 46 | 5.2 | 8.9 | 252 | 515 |
| ⩾3 persistent symptoms | 7 | 0 | 2.8 | 0.0 | 252 | 515 |
| Oxygen saturation on room air | ||||||
| Mean (range) | 97.8 (91–100) | 767 | ||||
| ⩾95% | 722 | 94.1 | 767 | |||
| 93-94% | 44 | 5.7 | 767 | |||
| <93% | 1 | 0.1 | 767 | |||
| Modified Medical Research Council dyspnoea Scale (mMRC) | ||||||
| Grade 0 – No dyspnoea | 539 | 70.3 | 767 | |||
| Grade 1 – Mild dyspnoea | 176 | 23.0 | 767 | |||
| Grade 2 – Moderate dyspnoea | 42 | 5.5 | 767 | |||
| Grade 3 – Severe dyspnoea | 10 | 1.3 | 767 | |||
| Grade 4 – Very severe dyspnoea | 0 | 0.0 | 767 | |||
| Karnofsky performance status scale | ||||||
| >90% | 640 | 90.9 | 704 | |||
| 80-90% | 51 | 7.2 | 704 | |||
| <80% | 13 | 1.8 | 704 | |||
COPD, chronic obstructive pulmonary disease; IES-R, Impact of Event Scale-Revised; HADS, Hospital Anxiety and Depression Scale; RSA, Resilience Scale for Adults; MoCA, Montreal Cognitive Assessment; LDH, lactate de-hydrogenase; TSH, thyroid stimulating hormone; CNS, central nervous system; PNS, peripheral nervous system.
FEV1: forced expiratory volume in the 1st second; FVC: forced expiratory volume); LLN: lower limit of normality; obstruction is defined by FEV1/FVC values below the LLN; restrictive pattern is defined by FVC values below the LLN; mixed pattern is defined by coexistence of obstruction and restrictive pattern; DLCO is considered reduced when below the LLN. All reference values are calculated with GLI 2012 for spirometry and GLI 2017 for DLCO equations.
Nephrology consultation, gastroenterology consultation, vascular surgery consultation.